Table. 1.

Study characteristics.

	Study	Country	Design	Participants	Age of participants (in years; range or mean ± SD)	Quarantine period	Evaluation methods
	Cheng et al., 2020	China	Cross-sectional	60 patients with COVID-19 and 60 patients suspected with COVID-19 (all quarantined)	NR	Length unclear; COVID-19 exposure	Self-developed questionnaire via online system (https://www.wjx.cn/)
	Dong et al., 2020	China	Cross-sectional	40 suspected COVID-19 patients being quarantined, and 38 residents not quarantined	21–50	Length unclear; COVID-19 exposure	GAD-7 and PHQ-9 to assess psychological disorders
	Ju et al., 2020	China	Case report	2 residents suspected with COVID-19	46 and 78	11 days and 12 days	Interview
	Ma et al., 2020	China	Cross-sectional	13 quarantined in hospital and 110 at home	Group 1: 35.38 ± 5.17;Group 2: 38.24 ± 11.01	Length unclear; COVID-19 exposure	SF-36 health survey, PSQI to evaluate the sleep quality and DASS-21 to evaluate general mental health
	Wang et al., 2020	China	Cross-sectional	396 children	12.8 ± 2.6	Length unclear; COVID-19 exposure; home quarantine	DSRS to assess depressive symptoms
	Li et al., 2020a	China	Cross-sectional	396 children and adolescents aged 8–18 years	12.8 ± 2.6	Length unclear; COVID-19 exposure; home quarantine	SCARED to assess anxiety symptoms
	Li et al., 2020b	China	Cross-sectional	76 quarantined in hospital	36 ± 15	Length unclear; COVID-19 exposure; hospital quarantine	HAMA to assess anxiety symptoms
	Zhong et al., 2020	China	Cross-sectional	20 quarantined in hospital	21–46	Length unclear; COVID-19 exposure; hospital quarantine	Self-developed questionnaire

NR: Not Report; GAD-7: Generalized Anxiety Disorder-7; PHQ-9: Patient Health Questionnaire; SF-36: Short-Form Health Survey-36 items; PSQI: Pittsburgh sleep quality index; DASS-21: Depression Anxiety Stress Scale 21; DSRS: Depression Self-rating Scale for Children; SCARED: Screen for Child Anxiety Related Emotional Disorders; HAMA: Hamilton Anxiety Scale; SD: standard deviation.